Study #2024-1319
Phase 1 imaging study of 68Ga-R10602 in hormone receptor-positive breast cancer
MD Anderson Study Status
Enrolling
Treatment Agent
68Ga-R10602 injection
Description
A phase 1 imaging study of 68Ga-R10602 in hormone-receptor positive breast cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Locoregionally Recurrent Hormone-receptor Positive Breast Cancer, Metastatic Hormone Receptor Positive Breast Cancer, Hormone Receptor Positive Breast Adenocarcinoma
Study phase:
Phase I
Physician name:
Sanjit Tewari
Department:
Nuclear Medicine
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop UT MD Anderson
Show your support for our mission through branded merchandise.